Producing striatal phenotypes for transplantation in Huntington's disease
Sophie V Precious1, Anne E Rosser
1Brain Repair Group, School of Biosciences, Cardiff University, Museum Avenue, Cardiff CF10 3AX, UK. precioussv@cf.ac.uk
Experimental Biology and Medicine (Maywood, N.J.)
|April 12, 2012
Summary
Neural transplantation offers hope for Huntington's disease (HD) by replacing lost brain cells. Research focuses on generating suitable medium-sized spiny neurons (MSN) for transplantation to restore circuitry and alleviate symptoms.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Cell Therapy
Background:
- Neurodegenerative disorders like Huntington's disease (HD) involve progressive loss of specific neuronal populations, such as medium-sized spiny neurons (MSN) in the striatum.
- This cellular deficit disrupts neural circuitry, leading to debilitating disease symptoms.
- Neural transplantation presents a potential therapeutic strategy to replace these lost cells and restore function.
Purpose of the Study:
- To review the progress in generating striatal medium-sized spiny neuron (MSN) phenotypes for transplantation in Huntington's disease (HD).
- To assess current and potential cell sources for transplantation therapies in HD.
- To evaluate the efficacy of directing renewable cell differentiation towards a striatal MSN phenotype for HD treatment.
Main Methods:
- Review of preclinical and clinical studies utilizing primary fetal striatal tissue for transplantation in HD models.
- Assessment of various renewable cell sources (e.g., stem cells) for their potential in generating MSN phenotypes.
- Evaluation of differentiation protocols aimed at directing renewable cells towards a striatal MSN fate.
Main Results:
- Primary fetal tissue has been used in both preclinical and clinical settings for striatal transplantation in HD.
- Renewable cell sources are being explored as alternatives to primary tissue, offering scalability and potential for controlled differentiation.
- Progress is being made in directing the differentiation of renewable cells to achieve a striatal MSN phenotype suitable for transplantation.
Conclusions:
- Neural transplantation is a promising therapeutic avenue for Huntington's disease (HD) due to the specific cell loss in the striatum.
- The development of renewable cell sources and effective differentiation protocols is crucial for advancing transplantation strategies in HD.
- Continued research into generating and transplanting functional striatal medium-sized spiny neurons (MSN) holds potential for alleviating HD symptoms.
